[
    {
        "Type of cases": "NSP Cured",
        "I Qtr 2021": "336",
        "II Qtr 2021": "235",
        "III Qtr 2021": "189",
        "IV Qtr 2021": "176",
        "Total 2021": "936",
        "%": "87.3"
    },
    {
        "Type of cases": "NSP Treatment completed",
        "I Qtr 2021": "5",
        "II Qtr 2021": "4",
        "III Qtr 2021": "3",
        "IV Qtr 2021": "1",
        "Total 2021": "13",
        "%": "1.2"
    },
    {
        "Type of cases": "NSP Died",
        "I Qtr 2021": "11",
        "II Qtr 2021": "8",
        "III Qtr 2021": "10",
        "IV Qtr 2021": "4",
        "Total 2021": "33",
        "%": "3.1"
    },
    {
        "Type of cases": "NSP Failure",
        "I Qtr 2021": "1",
        "II Qtr 2021": "0",
        "III Qtr 2021": "5",
        "IV Qtr 2021": "3",
        "Total 2021": "9",
        "%": "0.8"
    },
    {
        "Type of cases": "NSP Lost to Follow-up",
        "I Qtr 2021": "8",
        "II Qtr 2021": "7",
        "III Qtr 2021": "6",
        "IV Qtr 2021": "8",
        "Total 2021": "29",
        "%": "2.7"
    },
    {
        "Type of cases": "NSP Not Evaluated",
        "I Qtr 2021": "3",
        "II Qtr 2021": "2",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "1",
        "Total 2021": "6",
        "%": "0.6"
    },
    {
        "Type of cases": "NSP Treatment Regimen Changed",
        "I Qtr 2021": "13",
        "II Qtr 2021": "17",
        "III Qtr 2021": "3",
        "IV Qtr 2021": "13",
        "Total 2021": "46",
        "%": "4.3"
    },
    {
        "Type of cases": "NSP Total",
        "I Qtr 2021": "377",
        "II Qtr 2021": "273",
        "III Qtr 2021": "216",
        "IV Qtr 2021": "206",
        "Total 2021": "1072",
        "%": ""
    },
    {
        "Type of cases": "NSN/NEP Cured",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "0",
        "Total 2021": "0",
        "%": "0.0"
    },
    {
        "Type of cases": "NSN/NEP Treatment completed",
        "I Qtr 2021": "481",
        "II Qtr 2021": "409",
        "III Qtr 2021": "413",
        "IV Qtr 2021": "353",
        "Total 2021": "1656",
        "%": "93.1"
    },
    {
        "Type of cases": "NSN/NEP Died",
        "I Qtr 2021": "22",
        "II Qtr 2021": "8",
        "III Qtr 2021": "7",
        "IV Qtr 2021": "13",
        "Total 2021": "50",
        "%": "2.8"
    },
    {
        "Type of cases": "NSN/NEP Failure",
        "I Qtr 2021": "1",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "0",
        "Total 2021": "1",
        "%": "0.1"
    },
    {
        "Type of cases": "NSN/NEP Lost to Follow-up",
        "I Qtr 2021": "14",
        "II Qtr 2021": "10",
        "III Qtr 2021": "7",
        "IV Qtr 2021": "11",
        "Total 2021": "42",
        "%": "2.4"
    },
    {
        "Type of cases": "NSN/NEP Not Evaluated",
        "I Qtr 2021": "3",
        "II Qtr 2021": "1",
        "III Qtr 2021": "2",
        "IV Qtr 2021": "1",
        "Total 2021": "7",
        "%": "0.4"
    },
    {
        "Type of cases": "NSN/NEP Treatment Regimen Changed",
        "I Qtr 2021": "12",
        "II Qtr 2021": "1",
        "III Qtr 2021": "5",
        "IV Qtr 2021": "4",
        "Total 2021": "22",
        "%": "1.2"
    },
    {
        "Type of cases": "NSN/NEP Total",
        "I Qtr 2021": "533",
        "II Qtr 2021": "429",
        "III Qtr 2021": "434",
        "IV Qtr 2021": "382",
        "Total 2021": "1778",
        "%": ""
    },
    {
        "Type of cases": "RT +ve Cured",
        "I Qtr 2021": "92",
        "II Qtr 2021": "58",
        "III Qtr 2021": "54",
        "IV Qtr 2021": "35",
        "Total 2021": "239",
        "%": "83.0"
    },
    {
        "Type of cases": "RT+ve Treatment completed",
        "I Qtr 2021": "1",
        "II Qtr 2021": "4",
        "III Qtr 2021": "2",
        "IV Qtr 2021": "0",
        "Total 2021": "7",
        "%": "2.4"
    },
    {
        "Type of cases": "RT +Ve Died",
        "I Qtr 2021": "6",
        "II Qtr 2021": "3",
        "III Qtr 2021": "6",
        "IV Qtr 2021": "1",
        "Total 2021": "16",
        "%": "5.6"
    },
    {
        "Type of cases": "RT +ve Failure",
        "I Qtr 2021": "1",
        "II Qtr 2021": "0",
        "III Qtr 2021": "3",
        "IV Qtr 2021": "0",
        "Total 2021": "4",
        "%": "1.4"
    },
    {
        "Type of cases": "RT +ve Lost to Follow-up",
        "I Qtr 2021": "0",
        "II Qtr 2021": "1",
        "III Qtr 2021": "3",
        "IV Qtr 2021": "0",
        "Total 2021": "4",
        "%": "1.4"
    },
    {
        "Type of cases": "RT +ve Not Evaluated",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "1",
        "IV Qtr 2021": "0",
        "Total 2021": "1",
        "%": "0.3"
    },
    {
        "Type of cases": "RT +ve Treatment Regimen Changed",
        "I Qtr 2021": "2",
        "II Qtr 2021": "5",
        "III Qtr 2021": "4",
        "IV Qtr 2021": "6",
        "Total 2021": "17",
        "%": "5.9"
    },
    {
        "Type of cases": "RT +ve Total",
        "I Qtr 2021": "102",
        "II Qtr 2021": "71",
        "III Qtr 2021": "73",
        "IV Qtr 2021": "42",
        "Total 2021": "288",
        "%": ""
    },
    {
        "Type of cases": "RT Neg Cured",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "0",
        "Total 2021": "0",
        "%": "0.0"
    },
    {
        "Type of cases": "RT Neg Treatment completed",
        "I Qtr 2021": "75",
        "II Qtr 2021": "58",
        "III Qtr 2021": "50",
        "IV Qtr 2021": "57",
        "Total 2021": "240",
        "%": "96.0"
    },
    {
        "Type of cases": "RT Neg Died",
        "I Qtr 2021": "1",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "3",
        "Total 2021": "4",
        "%": "1.6"
    },
    {
        "Type of cases": "RT Neg Failure",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "0",
        "Total 2021": "0",
        "%": "0.0"
    },
    {
        "Type of cases": "RT Neg Lost to Follow-up",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "1",
        "IV Qtr 2021": "1",
        "Total 2021": "2",
        "%": "0.8"
    },
    {
        "Type of cases": "RT Neg Not Evaluated",
        "I Qtr 2021": "0",
        "II Qtr 2021": "0",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "0",
        "Total 2021": "0",
        "%": "0.0"
    },
    {
        "Type of cases": "RT Neg Treatment Regimen Changed",
        "I Qtr 2021": "0",
        "II Qtr 2021": "1",
        "III Qtr 2021": "0",
        "IV Qtr 2021": "3",
        "Total 2021": "4",
        "%": "1.6"
    },
    {
        "Type of cases": "RT Neg Total",
        "I Qtr 2021": "76",
        "II Qtr 2021": "59",
        "III Qtr 2021": "51",
        "IV Qtr 2021": "64",
        "Total 2021": "250",
        "%": ""
    }
]